logo

For the Inventor, By the Inventor

Oita, Japan

Tomonori Imayoshi

This inventor holds 6 USPTO granted patents. Top assignees: Yoshitomi Pharmaceutical Industries, Ltd., Welfide Corporation. Active years: 1986-2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tomonori Imayoshi. Retrieved from https://idiyas.com/inventor/tomonori-imayoshi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6

% Patents Active = 100.0

Average Co-Inventor Count = 4.3

ph-index = 5

Forward Citations = 73(Granted Patents)


Location History:

  • Nakatsu, JP (1988)
  • Oita, JP (1986 - 1989)
  • Fukuoka, JP (2000 - 2001)

Company Filing History:

goldMedal5 out of 198 
 
Yoshitomi Pharmaceutical Industries, Ltd.
 patents
silverMedal1 out of 13 
 
Welfide Corporation
 patents

Years Active: 1986-2001

Loading Chart...
6 patents (USPTO):Explore Patents
1. 6197829 - External preparation of 2-amino-2-(2-(4-octylphenyl)ethyl) propane-1,3-diol or pharmaceutically acceptable salts thereof for topical administration (2001-03-06),
2. 6121329 - Topical administration of (2000-09-19),
3. 4808620 - Pyrazolopyridine compounds, their preparation and use as platelet (1989-02-28),
4. 4808593 - Benzopyranopyridineacetic acid ester compounds and their pharmaceutical (1989-02-28),
5. 4728644 - Purine derivative and pharmaceutical composition (1988-03-01),
6. 4576940 - Anti-allergic 3-indolecarboxamides (1986-03-18),

Title: The Innovations of Tomonori Imayoshi

Introduction

Tomonori Imayoshi is a notable inventor based in Oita, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of topical preparations aimed at treating various medical conditions. With a total of 6 patents to his name, Imayoshi's work has had a meaningful impact on the industry.

Latest Patents

One of his latest patents involves an external preparation of 2-amino-2-(2-(4-octylphenyl)ethyl) propane-1,3-diol or pharmaceutically acceptable salts thereof for topical administration. This innovative formulation aims to inhibit rejection reactions during organ or bone marrow transplantation and to treat autoimmune diseases or allergic diseases. The active ingredient, 2-amino-2-(2-(4-octylphenyl)ethyl)propane-1,3-diol, is designed for effective topical administration.

Career Highlights

Throughout his career, Imayoshi has worked with prominent companies in the pharmaceutical sector, including Yoshitomi Pharmaceutical Industries, Ltd. and Welfide Corporation. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research and development.

Collaborations

Imayoshi has collaborated with esteemed colleagues such as Michio Terasawa and Tsuneo Fujii. These partnerships have fostered a collaborative environment that has led to innovative solutions in the pharmaceutical field.

Conclusion

Tomonori Imayoshi's contributions to pharmaceutical innovations demonstrate his commitment to improving medical treatments through his inventions. His work continues to influence the industry and offers hope for advancements in the treatment of various diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…